Portuguese study of familial dilated cardiomyopathy: the FATIMA study

Elisabete Martins1, José Silva-Cardoso, Manuel Bicho

  • 1Serviço de Cardiologia-Hospital de São João, Faculdade de Medicina do Porto, Porto, Portugal. bernardes_med@hotmail.com

Insights

Dilated cardiomyopathy (DCM) is a genetic heart condition. This study outlines a multicenter approach to identify genetic mutations in familial DCM cases within the Portuguese population.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Dilated cardiomyopathy (DCM) is a myocardial disease affecting ventricular function, with over 30% of cases having a genetic origin.
  • DCM often manifests in adulthood with heart failure, arrhythmias, or sudden death, typically inherited in an autosomal dominant pattern.
  • Previous studies have focused on limited gene screenings, leaving the epidemiology of familial DCM mutations largely unknown.

Purpose of the Study:

  • To describe the methodology for a multicenter study on familial DCM.
  • To facilitate the clinical and molecular characterization of familial DCM patients in Portugal.
  • To address the knowledge gap in the epidemiology of genetic mutations in familial DCM.

Main Methods:

  • Implementing a multicenter study design.
  • Screening for a wide range of mutations in familial and idiopathic DCM cases.
  • Conducting thorough clinical and molecular characterization of affected individuals.

Main Results:

  • Methodology for a comprehensive multicenter study on familial DCM established.
  • Framework for genetic mutation screening and clinical characterization developed.
  • Foundation laid for understanding DCM epidemiology in the Portuguese population.

Conclusions:

  • A robust multicenter study methodology is crucial for elucidating the genetic basis of DCM.
  • Comprehensive genetic screening and clinical data are needed to understand familial DCM epidemiology.
  • This study will provide critical insights into DCM in the Portuguese population.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...